Abstract
COVID-19 pandemic is caused by highly infectious SARS-CoV-2. Observational studies have documented several neurological complications or associations either during or after the COVID-19. Some of them, have reported some case reports regarding COVID-19 in patients with a known history of myasthenia gravis (MG) but new onset of autoimmune MG in patients with COVID-19 is scarcely reported. Here, we report two novel cases of new-onset autoimmune MG following COVID-19 and describe the clinical and paraclinical findings in the context of other scarce reported cases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
